Evidence map›Paper›PMID 34802196›Full record

ArticleAnnals of clinical and translational neurology2021

Using electronic health data to explore effectiveness of ICU EEG and anti-seizure treatment.

Rajesh Amerineni, Haoqi Sun, Hang Lee, John Hsu, Elisabetta Patorno, Michael Brandon Westover, Sahar F Zafar

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Rajesh AmerineniDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Haoqi SunDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Hang LeeDepartment of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
John HsuDepartment of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Elisabetta PatornoDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Michael Brandon WestoverDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0003-4803-312X
Sahar F ZafarDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0001-5252-5376
Massachusetts General Hospital · USBrigham and Women's Hospital · USHarvard University · US

Funding

Optimizing anti-epileptic drug treatment in acute brain injuryK23NS114201 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ZAFAR, SAHAR F · 2019 to 2023
$1.0M
NIH HHS K23NS114201NINDS NIH HHS K23 NS114201
6 · The paper itself

Abstract

objectivesThe purpose of this study was to examine critical care continuous electroencephalography (cEEG) utilization and downstream anti-seizure treatment patterns, their association with outcomes, and generate hypotheses for larger comparative effectiveness studies of cEEG-guided interventions.

methodsSingle-center retrospective study of critically ill patients (n = 14,523, age ≥18 years). Exposure defined as ≥24 h of cEEG and subsequent anti-seizure medication (ASM) escalation, with or without concomitant anesthetic. Exposure window was the first 7 days of admission. Primary outcome was in-hospital mortality. Multivariable analysis was performed using penalized logistic regression.

resultsOne thousand and seventy-three patients underwent ≥24 h of cEEG within 7 days of admission. After adjusting for disease severity, ≥24 h of cEEG followed by ASM escalation in patients not on anesthetics (n = 239) was associated with lower in-hospital mortality (OR 0.76 [0.53-1.07]), though the finding did not reach significance. ASM escalation with concomitant anesthetic use (n = 484) showed higher odds for mortality (OR 1.41 [1.03-1.94]). In the seizures/status epilepticus subgroup, post cEEG ASM escalation without anesthetics showed lower odds for mortality (OR 0.43 [0.23-0.74]). Within the same subgroup, ASM escalation with concomitant anesthetic use showed higher odds for mortality (OR 1.34 [0.92-1.91]) though not significant.

interpretationBased on our findings we propose the following hypotheses for larger comparative effectiveness studies investigating the direct causal effect of cEEG-guided treatment on outcomes: (1) cEEG-guided ASM escalation may improve outcomes in critically ill patients with seizures; (2) cEEG-guided treatment with combination of ASMs and anesthetics may not improve outcomes in all critically ill patients.

Indexed as

SeizuresAgedAnticonvulsantsCritical CareElectroencephalographyElectronic Health RecordsFemaleHospital MortalityHumansIntensive Care UnitsMaleMiddle AgedNeurophysiological MonitoringOutcome and Process Assessment, Health CarePatient DischargeRetrospective StudiesAnticonvulsants

Identifiers

PMID34802196
PMCPMC8670316
OpenAlexW3217480871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.